What if you could spot stocks early—before they become the talk of the market? Investors often chase fundamentally strong ...

In recent years, the pharmaceutical industry has undergone a major transformation in research and development approaches, ...

(Reuters) -Federal prosecutors in Manhattan are probing a claim by GSK that Pfizer delayed announcing its COVID shot's ...

Wave Life Sciences Ltd. shares promising updates on AATD & DMD treatments. Click here for my updated look at WVE stock ...

The new antibiotic developed by GSK attacks a different part of the bacteria than other drugs, making it more effective ...

GSK Plc is pushing the UK government to give pharmaceutical companies more access to its public health data troves, to ...

Key TakeawaysBlujepa (gepotidacin) is the first new antibiotic class approved in nearly 30 years, providing a crucial ...

Stock analysts at Zacks Research upped their FY2027 earnings per share estimates for GSK in a report issued on Tuesday, March ...

The Food and Drug Administration has approved a new antibiotic that can treat uncomplicated urinary tract infections, or ...

We recently published a list of Jim Cramer Discussed These 6 Stocks Recently. In this article, we are going to take a look at ...

SPR720 is an investigational, chemically stable phosphate ester prodrug that is converted rapidly in vivo to SPR719, the ...

The US Food and Drug Administration (FDA) has early this week approved GSK's new antibiotic, Blujepa (gepotidacin), for the ...